{"status": "ok", "totalResults": 2, "articles": [{"source": {"id": "financial-times", "name": "Financial Times"}, "author": "Ivan Levingston, George Hammond, Tabby Kinder, Leo Lewis", "title": "SoftBank's $50bn Arm IPO more than five times oversubscribed, bankers say - Financial Times", "description": "Some fund managers on US roadshow see red flags in small size of listing and large number of banks involved", "url": "https://www.ft.com/content/a4dc854b-cdf9-4c13-b973-f39b3fa917a4", "urlToImage": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F7c437a32-4139-4574-ae80-204b7df90809.jpg?source=next-opengraph&fit=scale-down&width=900", "publishedAt": "2023-09-08T16:43:19Z", "content": "SoftBanks $50bn flotation of Arm is more than five times oversubscribed, according to bankers pitching investors on the biggest initial public offering in nearly two years, as the UK-based chip desig\u2026 [+5378 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters", "title": "Lilly's diabetes drug gains backing of UK watchdog -Bloomberg News - Reuters", "description": "Eli Lilly's <a href=\"https://www.reuters.com/markets/companies/LLY.N\" target=\"_blank\">(LLY.N)</a> diabetes drug Mounjaro has gained the backing of Britain's healthcare cost-effectiveness watchdog, which said it would be a good option for patients with poorly \u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/lillys-diabetes-drug-gains-backing-uk-watchdog-bloomberg-news-2023-09-08/", "urlToImage": "https://www.reuters.com/resizer/1ZmgZD1C5NptBvvfCEsA5an61Nk=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/FAQTJ67KUNKL3H6NZ4DIJMOMOI.jpg", "publishedAt": "2023-09-08T01:58:00Z", "content": "Sept 8 (Reuters) - Eli Lilly's (LLY.N) diabetes drug Mounjaro has gained the backing of Britain's healthcare cost-effectiveness watchdog, which said it would be a good option for patients with poorly\u2026 [+1477 chars]"}]}